Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

Most cases of adult-onset (AO) GH deficiency (GHD) result from the presence of hypothalamo-pituitary tumors or their treatment. GH replacement is now widely used in adults with hypopituitarism, but its effect on hypothalamo-pituitary tumor growth or recurrence is unknown. Anecdotal evidence from ear...

Full description

Bibliographic Details
Main Authors:	Frajese, G, Drake, WM, Loureiro, R, Evanson, J, Coyte, D, Wood, D, Grossman, AB, Besser, G, Monson, J
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
by: Chung, T, et al.
Published: (2008)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
by: Drake, WM, et al.
Published: (1998)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
by: Chung, T, et al.
Published: (2005)

Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
by: Kaltsas, G, et al.
Published: (2000)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
by: Agha, A, et al.
Published: (2007)

Therapeutic effects of neuroactive drugs on hypothalamo-pituitary in man.
by: Trainer, P, et al.
Published: (1990)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
by: Sverrisdóttir, Y, et al.
Published: (2003)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
by: Colson, A, et al.
Published: (2008)

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
by: Florakis, D, et al.
Published: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
by: Monson, J, et al.
Published: (2001)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
by: Korbonits, M, et al.
Published: (1999)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
by: le Roux, C, et al.
Published: (2002)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
by: Chung, T, et al.
Published: (2010)

Recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal adenomectomy for non–ACTH-secreting macroadenomas
by: Pofi, R, et al.
Published: (2019)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
by: Swords, F, et al.
Published: (2009)

The short Synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function
by: Pofi, R, et al.
Published: (2018)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
by: Colson, A, et al.
Published: (2006)

A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy.
by: Mukherjee, J, et al.
Published: (1997)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
by: Korbonits, M, et al.
Published: (1999)

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
by: Swords, F, et al.
Published: (2003)

Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone.
by: Delitala, G, et al.
Published: (1989)

Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease.
by: Storr, H, et al.
Published: (2014)

Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects.
by: Castro, R, et al.
Published: (1990)

Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas.
by: Salvatori, R, et al.
Published: (2001)

The diagnosis and management of parasellar tumours of the pituitary.
by: Kaltsas, G, et al.
Published: (2008)

CALCULATION OF PITUITARY GROWTH-HORMONE (GH) SECRETION RATE IN CHILDREN
by: Hindmarsh, P, et al.
Published: (1988)

Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
by: Storr, H, et al.
Published: (2014)

Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.
by: Weaver, J, et al.
Published: (1993)

Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
by: Isidori, A, et al.
Published: (2002)

Pattern analysis of the colocalization of FSH and GH in human fetal pituitary cells
by: Chirculescu, A, et al.
Published: (2008)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
by: Kaltsas, G, et al.
Published: (1998)

Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
by: Ross, R, et al.
Published: (1990)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
by: Arnold, JR, et al.
Published: (2009)

Studies off the opiate control of prolactin, GH and TSH.
by: Grossman, A, et al.
Published: (1981)

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma.
by: Allan, C, et al.
Published: (2001)

Anterior pituitary function in the long-term follow-up of five paediatric Cushing's disease patients treated with pituitary radiotherapy
by: Chan, L, et al.
Published: (2006)

Clinical case seminar - Pituitary chondrosarcoma: An unusual cause of a sellar mass presenting as a pituitary adenoma
by: Allan, C, et al.
Published: (2001)

The regulation of prolactin release by the anterior pituitary
by: Besser, G, et al.
Published: (1979)

Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function.
by: Lafont, C, et al.
Published: (2010)

Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.
by: Megan Ogilvie, C, et al.
Published: (2005)